Skip to main content
    N

    Neuroone Medical Technologies Corp (NMTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.71
    -0.04 (-5.15%)

    Market Cap: $6.78M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Neuroone Medical Technologies Corp (NMTC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Neuroone Medical Technologies (NMTC) has a market cap of $6.78M and an enterprise value of $4.81M. It kept -71.51% of revenue as net income over the last 12 months. Revenue grew 50.82% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 29.10% below the market cap, as cash exceeds debt.

    Market Cap$6.78M
    Enterprise Value$4.81M
    Latest price (Nov 17, 2026)$0.71

    Key Dates

    The next earnings report is set for Dec 15, 2026, after the close.

    Next Earnings DateDec 15, 2026, after the close
    Last Earnings DateAug 13, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 2.17% in the quarter ended Jun 30, 2026 and grew 38.46% a year over 2 years.

    Shares Outstanding8.74M
    Shares Change (YoY)+7.88%
    Shares Change (QoQ)+2.17%
    Share Count Growth (2Y CAGR)+38.46%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 1.6x.

    P/S Ratio0.6x
    Forward P/S0.5x
    P/B Ratio1.6x
    P/TBV Ratio1.7x

    Price Statistics

    The stock is down 82.92% over 52 weeks and trades 34.26% below its 50-day average.

    Beta (1Y)0.80
    52-Week Change-82.92%
    1-Month Change-29.34%
    3-Month Change-67.59%
    6-Month Change-82.81%
    5-Year Change-94.52%
    Total Return (1Y)-82.92%
    Total Return (3Y CAGR)-55.25%
    Total Return (5Y CAGR)-45.61%
    Max Drawdown (1Y)-87.99%
    Max Drawdown (3Y)-93.87%
    Sharpe Ratio (1Y)-2.01
    Correlation with SPY (1Y)0.13
    50-Day Average$1.08
    200-Day Average$2.93
    52-Week Range$0.74 to $6.12
    RSI (14 Days)30.9
    Average Volume (20 Days)65.55K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.84x current liabilities, and total debt is 0.02x shareholder equity.

    Current Ratio2.84x
    Quick Ratio1.71x
    Debt / Equity0.02x

    Returns and Efficiency

    Return on invested capital is -147.05% and return on equity is -189.76% over the last 12 months.

    Return on Equity (ROE)-189.76%
    Return on Assets (ROA)-115.57%
    Return on Invested Capital (ROIC)-147.05%
    Asset Turnover1.18x
    Inventory Turnover2.13x
    Receivables Turnover5.67x
    Cash Conversion Cycle160 days

    Scores

    NMTC has an Altman Z-Score of -19.05, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-19.05
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $10.00M over the last 12 months.

    Revenue$10.00M
    Revenue Growth (YoY)+50.82%
    Gross Profit$5.57M
    Operating Income-$7.60M
    Pretax Income-$7.15M
    Net Income-$7.15M
    EBITDA-$6.91M
    Reported EPS (TTM)-$0.74

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 60.90% of the $6.19M in total assets.

    Cash and Equivalents$2.05M
    Total Debt$73.32K
    Net Cash$1.97M
    Net Cash Per Share$0.23
    Working Capital$3.75M
    Shareholder Equity$3.77M
    Book Value Per Share$0.43
    Tangible Book Value$3.74M
    Tangible Book Per Share$0.43
    Total Assets$6.19M
    Total Liabilities$2.42M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $109.54K of capital spending, operating cash flow left -$7.16M of free cash flow.

    Operating Cash Flow-$7.05M
    Capital Expenditures$109.54K
    Free Cash Flow-$7.16M
    FCF Per Share-$0.79
    Depreciation and Amortization$236.88K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -76.05%.

    Gross Margin55.67%
    Operating Margin-76.05%
    Pretax Margin-71.51%
    Net Margin-71.51%
    EBITDA Margin-69.14%
    FCF Margin-71.63%
    Gross Margin (5Y Average)5.14%

    Growth

    Revenue grew 313.45% a year over 3 years.

    Revenue Growth (3Y CAGR)+313.45%
    Revenue Growth (5Y CAGR)+44.41%
    Book Value Per Share Growth (2Y CAGR)-18.58%
    Tangible Book Per Share Growth (2Y CAGR)-18.25%

    Revenue and profit by year

    Dividends and Yields

    NMTC does not pay a dividend. Its free cash flow yield is -115.97%.

    FCF Yield-115.97%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-6 reverse split on Apr 16, 2026.

    Last Split DateApr 16, 2026
    Split TypeReverse split
    Split Ratio1:6

    Peer Position

    Against 7 similar companies, NMTC has the 4th highest P/S.

    P/S Ratio0.6x vs 0.6x median
    ROIC-147.05% vs -164.51% median
    Revenue Growth (Trailing 4 Quarters, YoY)+50.82% vs +18.57% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About NMTC

    What is NMTC's market cap?

    Neuroone Medical Technologies has a market cap of $6.78M. Its enterprise value, which adds debt and subtracts cash, is $4.81M.

    How many shares of NMTC are outstanding?

    Neuroone Medical Technologies has 8.74M shares outstanding. The count is up 7.88% from a year earlier.

    Does NMTC pay a dividend?

    No. Neuroone Medical Technologies does not pay a dividend.

    How much debt does NMTC have?

    Neuroone Medical Technologies has $73.32K of total debt and $2.05M of cash and equivalents, a net cash position of $1.97M.